Related Experiment Video
Updated: Aug 27, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Circular RNAs in Diabetic Nephropathy: Updates and Perspectives
1Department of Nephrology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, Shanghai 201318, China.
Circular RNAs (circRNAs), stable molecules, are crucial in diabetes complications like diabetic nephropathy (DN). Understanding circRNA roles in DN offers new therapeutic avenues for kidney disease management.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Circular RNAs (circRNAs) are unique RNA molecules with a closed-loop structure, conferring high stability.
- These stable circRNAs are implicated in the pathogenesis of various diseases, including diabetes.
- Diabetic nephropathy (DN) is a severe complication of diabetes, leading to end-stage kidney disease.
Purpose of the Study:
- To review the fundamental characteristics and functions of circRNAs.
- To summarize recent findings on the involvement of circRNAs in diabetic nephropathy (DN).
- To propose future research directions for circRNAs in DN for improved treatment and management.
Main Methods:
- Literature review of existing studies on circRNAs and diabetic nephropathy.
- Analysis of the roles and mechanisms of circRNAs in DN pathophysiology.
- Synthesis of current knowledge and identification of research gaps.
Main Results:
- CircRNAs exhibit distinct features, including stability and diverse regulatory functions.
- Emerging evidence highlights the significant role of specific circRNAs in the development and progression of DN.
- CircRNAs are involved in various cellular processes relevant to DN, such as inflammation, fibrosis, and oxidative stress.
Conclusions:
- CircRNAs are critical players in diabetic nephropathy (DN) pathogenesis.
- Further investigation into circRNAs in DN is essential for developing novel diagnostic and therapeutic strategies.
- Targeting circRNAs holds promise for managing diabetic kidney disease.
More Related Videos
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
06:48Quantitative Real-Time Polymerase Chain Reaction Evaluation of MicroRNA Expression in Kidney and Serum of Mice with Age-Dependent Renal Impairment
Published on: April 29, 2022
Related Concept Videos
Chronic Kidney Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome I : Introduction